Sanliurfa Education and Research Hospital
Sanliurfa, Şanlıurfa, 63200, Turkey (Türkiye)
Location contact
Sanliurfa Education and Research Hospital bostancı erkmen, MD
CONTACT
melike bostancı erkmen, MD
CONTACT
NCT Number: NCT07547280
The primary aim of this study was to investigate the effects of the external oblique intercostal plane block and the subcostal transversus abdominis plane block on postoperative pain scores and opioid consumption in patients undergoing laparoscopic sleeve gastrectomy.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Sanliurfa, Şanlıurfa, 63200, Turkey (Türkiye)
Sanliurfa Education and Research Hospital bostancı erkmen, MD
CONTACT
melike bostancı erkmen, MD
CONTACT
Obesity is a global health problem currently treated with diet, pharmacotherapy, and bariatric surgery. Laparoscopic sleeve gastrectomy (LSG) is a common bariatric procedure that often results in moderate to severe postoperative pain. Adequate pain control after LSG is crucial for early mobilization and prevention of complications . As a relatively novel technique, the external oblique intercostal block (EOIB) provides analgesia for anterolateral upper abdominal surgery by blocking both the lateral and anterior cutaneous branches of the intercostal nerves between T6-7 and T10-11 . The subcostal transversus abdominis plane (s-TAP) block provides sensory blockade over nearly the entire anterior abdominal wall between T6 and T9. Therefore, it can be considered as part of multimodal analgesia for both laparotomy and laparoscopic abdominal surgical procedures.
The primary aim of this study was to investigate the effects of the external oblique intercostal block (EOIB) and the subcostal transversus abdominis plane (s-TAP) block on postoperative pain scores and opioid consumption in patients undergoing laparoscopic sleeve gastrectomy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound-guided external oblique intercostal plane block will be performed at the T6 level using 20 ml of 0.25% bupivacaine at the Immediately after intubation
Port-site local anesthetic infiltration will be performed with bupivacain after intubation by surgeon.
Ultrasound-guided OSTAP block will be performed using 20 ml of 0.25% bupivacaine immediately after intubation.
Time frame: postoperative T1: 0. hours, T2:4.hours,T3:12.hours,T4: 24.hours
Postoperative acute pain scores assingment with Visual Analog Scores
Time frame: POSTOPERATİVE T1:0 HOURS T2:4. HOURS T3:12.HOURS T4:24.HOURS
We plan to investigate the effects of the external oblique intercostal block and the subcostal transversus abdominis plane block onopioid consumption in patients undergoing laparoscopic sleeve gastrectomy after surgery.
Time frame: Postoperative 24.hours
Secondary outcomes will include patient- and surgeon-based Likert scale assessments.
Time frame: Postoperative first 24.hours
Contact information is provided by the study sponsor or research team.
MELİKE BOSTANCI ERKMEN, MD
CONTACT
Tolga Karaçay, MD
CONTACT
Sanliurfa Education and Research Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07591116
External Oblique Intercostal Plane Block, Intertransverse Process Block
View Trial DetailsNCT07591129
Intertransverse Process Block, Neurologic Manifestations
Antalya, Turkey (Türkiye)
View Trial DetailsNCT07607067
Barrett Esophagus, Deglutition Disorders
View Trial DetailsNCT06767787
Arthritis, Arthroplasties, Knee Replacement
St. John's, Newfoundland and Labrador, Canada
View Trial Details